Loss of Virologic Control and Severe Pneumocystis pneumonia in an HIV-Infected Patient Receiving Chemotherapy for Non-Small Cell Lung Cancer

MeSH terms

• Anti-Bacterial Agents / therapeutic use
• Antineoplastic Agents / therapeutic use
• Antiretroviral Therapy, Highly Active / methods
• Carcinoma, Non-Small-Cell Lung / complications
• Carcinoma, Non-Small-Cell Lung / diagnostic imaging*
• Carcinoma, Non-Small-Cell Lung / drug therapy
• Cisplatin / therapeutic use
• Emtricitabine / therapeutic use
• Female
• HIV Infections / complications
• HIV Infections / diagnosis*
• HIV Infections / drug therapy
• HIV Infections / virology
• HIV-1 / drug effects
• HIV-1 / growth & development
• Heterocyclic Compounds, 3-Ring / therapeutic use
• Humans
• Lung Neoplasms / complications
• Lung Neoplasms / diagnostic imaging*
• Lung Neoplasms / drug therapy
• Middle Aged
• Oxazines
• Pemetrexed / therapeutic use
• Piperazines
• Pneumocystis carinii / drug effects
• Pneumocystis carinii / growth & development
• Pneumocystis carinii / pathogenicity
• Pneumonia, Pneumocystis / complications
• Pneumonia, Pneumocystis / diagnostic imaging*
• Pneumonia, Pneumocystis / drug therapy
• Pneumonia, Pneumocystis / microbiology
• Pyridones
• Tenofovir / therapeutic use
• Tomography, X-Ray Computed
• Treatment Outcome
• Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use
• Viral Load / drug effects